Global Bioinformatics Service Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

When it comes to offering critical support to various fields of scientific study, bioinformatics services have always had enormous potential. Bioinformatics is the study of biological data and the development of methods and software tools to understand it better. Bioinformatics is utilized in biological applications, including genomics, drug development, structural biology research, and biomedical imaging. Bioinformatics is also used to organize and retrieve data and evaluate numerous experimental elements with the help of contemporary analytical tools.

Market Dynamics:

The global bioinformatics services market has proliferated over the last decade due to technological advancements, increased information technology use in health care, and increased demand for data management tools in the life sciences and biotechnology research sectors. Additionally, increased research and development activities in biotechnology, drug discovery, and biopharmaceuticals are significant drivers impacting the market's growth. Furthermore, increased government initiatives contribute to the global expansion of the biotechnology market. Moreover, many organizations, such as those in the food, bioremediation, farming, measurement, and buyer industries, are using bioinformatics administrations to improve the quality of their products and store network measures. Bioinformatics services such as data fusion, control, lead disclosure, information the board, in silico examination, and businesses of all sizes are increasingly adopting improved information disclosure. This expansion of bioinformatics services' application sectors is essential to create new revenue streams for market participants, which will support the selection of these services and lead to overall market growth. The high cost of services and scarcity of experienced bioinformatics professionals, on the other hand, may hinder industry expansion.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of bioinformatics service. The growth and trends of bioinformatics service industry provide a holistic approach to this study.

Market Segmentation:

This section of the bioinformatics service market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Drug Development
Gene Therapy
Molecular Medicine
Veterinary Science
Others

By End Users/Applications

Academics And Research Centers
Pharmaceutical And Biotechnology Industries
Forensics Laboratories
Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Bioinformatics Service market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the bioinformatics service market include Illumina, Thermo Fisher Scientific, Strand Life Sciences, CD Genomics, Biomax Informatics, DNANEXUS, Agilent Technologies, QIAGEN, Gene Codes, BGI Group, Gene Code, PerkinElmer, Premier Biosoft, Biomatters Geneious, Creative-Biolabs, DNASTAR, GSL Biotech LLC (SnapGene), FIOS Genomics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11217038

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . BIOINFORMATICS SERVICE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 By Product Type
- 3.7.2 By End Users
- 3.7.3 By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL BIOINFORMATICS SERVICE MARKET ANALYSIS BY PRODUCT TYPE

6.1 Overview by Product Type
6.2 Historical and Forecast Data
6.3 Analysis by Product Type
6.4 Drug Development Market by Regions
6.6 Gene Therapy Market by Regions
6.5 Molecular Medicine Market by Regions
6.7 Veterinary Science Market by Regions
6.8 Others Market by Regions

7 . GLOBAL BIOINFORMATICS SERVICE MARKET ANALYSIS BY END USERS

7.1 Overview by End Users
7.2 Historical and Forecast Data
7.3 Analysis by End Users
7.4 Academics and Research Centers Market by Regions
7.5 Pharmaceutical and Biotechnology Industries Market by Regions
7.6 Forensics Laboratories Market by Regions
7.7 Others Market by Regions

8 . GLOBAL BIOINFORMATICS SERVICE MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America
- 8.3.1. Overview, Historic and Forecast Data
- 8.3.2. North America By Segment
- 8.3.3. North America By Country
- 8.3.4. United State
- 8.3.5. Canada
- 8.3.6. Mexico
8.4. Europe
- 8.4.1. Overview, Historic and Forecast Data
- 8.4.2. Europe by Segment
- 8.4.3. Europe by Country
- 8.4.4. United Kingdom
- 8.4.5. France
- 8.4.6. Germany
- 8.4.7. Italy
- 8.4.8. Russia
- 8.4.9. Rest Of Europe
8.5. Asia Pacific
- 8.5.1. Overview, Historic and Forecast Data
- 8.5.2. Asia Pacific by Segment
- 8.5.3. Asia Pacific by Country
- 8.5.4. China
- 8.5.5. India
- 8.5.6. Japan
- 8.5.7. South Korea
- 8.5.8. Australia
- 8.5.9. Rest Of Asia Pacific
8.6. Latin America
- 8.6.1. Overview, Historic and Forecast Data
- 8.6.2. Latin America by Segment
- 8.6.3. Latin America by Country
- 8.6.4. Brazil
- 8.6.5. Argentina
- 8.6.6. Peru
- 8.6.7. Chile
- 8.6.8. Rest of Latin America
8.7. Middle East & Africa
- 8.7.1. Overview, Historic and Forecast Data
- 8.7.2. Middle East & Africa by Segment
- 8.7.3. Middle East & Africa by Country
- 8.7.4. Saudi Arabia
- 8.7.5. UAE
- 8.7.6. Israel
- 8.7.7. South Africa
- 8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE BIOINFORMATICS SERVICE COMPANIES

9.1. Bioinformatics Service Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF BIOINFORMATICS SERVICE INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Illumina
- 10.3.1. Company Overview
- 10.3.2. Financials
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Thermo Fisher Scientific
- 10.4.1. Company Overview
- 10.4.2. Financials
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Strand Life Sciences
- 10.5.1. Company Overview
- 10.5.2. Financials
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. CD Genomics
- 10.6.1. Company Overview
- 10.6.2. Financials
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Biomax Informatics
- 10.7.1. Company Overview
- 10.7.2. Financials
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. DNANEXUS
- 10.8.1. Company Overview
- 10.8.2. Financials
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Agilent Technologies
- 10.9.1. Company Overview
- 10.9.2. Financials
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. QIAGEN
- 10.10.1. Company Overview
- 10.10.2. Financials
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Gene Codes
- 10.11.1. Company Overview
- 10.11.2. Financials
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. BGI Group
- 10.12.1. Company Overview
- 10.12.2. Financials
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. Gene Code
- 10.13.1. Company Overview
- 10.13.2. Financials
- 10.13.3. Products
- 10.13.4. Recent Developments
10.14. PerkinElmer
- 10.14.1. Company Overview
- 10.14.2. Financials
- 10.14.3. Products
- 10.14.4. Recent Developments
10.15. Premier Biosoft
- 10.15.1. Company Overview
- 10.15.2. Financials
- 10.15.3. Products
- 10.15.4. Recent Developments
10.16. Biomatters Geneious
- 10.16.1. Company Overview
- 10.16.2. Financials
- 10.16.3. Products
- 10.16.4. Recent Developments
10.17. Creative-Biolabs
- 10.17.1. Company Overview
- 10.17.2. Financials
- 10.17.3. Products
- 10.17.4. Recent Developments
10.18. DNASTAR
- 10.18.1. Company Overview
- 10.18.2. Financials
- 10.18.3. Products
- 10.18.4. Recent Developments
10.19. GSL Biotech LLC (SnapGene)
- 10.19.1. Company Overview
- 10.19.2. Financials
- 10.19.3. Products
- 10.19.4. Recent Developments
10.20. FIOS Genomics
- 10.20.1. Company Overview
- 10.20.2. Financials
- 10.20.3. Products
- 10.20.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies